Tomáš Sedlačík

Tomáš Sedlačík

Auto-generated profile, based on publicly available information

Tomáš Sedlačík

Supramolecular Chemistry Group, Centre of Macromolecular Chemistry (CMaC), Department of Organic and Macromolecular Chemistry, Ghent University, Krijgslaan 281-S4, Ghent 9000, Belgium

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 September 2020 in Chemistry of Materials
Verified
Journal Article
Closed access
TSTomáš Sedlačík
Tomáš Sedlačík
TNTakayuki Nonoyama
Takayuki Nonoyama
HGHonglei Guo
Honglei Guo
RKRyuji Kiyama
Ryuji Kiyama
NTNakajima Tasuku
Nakajima Tasuku
JGJianping Gong
Jianping Gong

18 November 2022 in Advanced Materials
Verified
Journal Article
Closed access
RKRyuji Kiyama
Ryuji Kiyama
MYMasahiro Yoshida
Masahiro Yoshida
TNTakayuki Nonoyama
Takayuki Nonoyama
TSTomáš Sedlačík
Tomáš Sedlačík
HJHiroshi Jinnai
Hiroshi Jinnai
JGJianping Gong
Jianping Gong

15 November 2019 in Biomaterials Science
Verified
Journal Article
Open access
PDF file
Naresh KasojuNaresh Kasoju
Naresh Kasoju
APAlžběta Pátíková
Alžběta Pátíková
EWEdyta Wawrzynska
Edyta Wawrzynska
AVAlžběta Vojtíšková
Alžběta Vojtíšková
TSTomáš Sedlačík
Tomáš Sedlačík
DKDana Kubies
Dana Kubies
The effectiveness of cell transplantation can be improved by optimization of the transplantation site. For some types of cells that form highly oxygen-demanding tissue, e.g., pancreatic islets, a successful engraftment depends on immediate and sufficient blood supply. This critical point can be avoided when cells are transplanted into a bioengineered pre-vascularized cavity which can be formed using a polymer scaffold. In our study, we tested surface-modified poly(lactide-co-caprolactone) (PLCL) capsular scaffolds containing the pro-angiogenic factor VEGF. After each modification step (i.e., amination and heparinization), the surface properties and morphology of scaffolds were characterized by ATR-FTIR and XPS spectroscopy, and by SEM and AFM. All modifications preserved the gross capsule morphology and maintained the open pore structure. Optimized aminolysis conditions decreased the Mw of PLCL only up to 10% while generating a sufficient number of NH2 groups required for the covalent immobilization of heparin. The heparin layer served as a VEGF reservoir with an in vitro VEGF release for at least four weeks. In vivo studies revealed that to obtain highly vascularized PLCL capsules (a) the optimal VEGF dose for the capsule was 50 μg and (b) the implantation time was four weeks when implanted into the greater omentum of Lewis rats; dense fibrous tissue accompanied by vessels completely infiltrated the scaffold and created sparse granulation tissue within the internal cavity of the capsule. The prepared pre-vascularized pouch enabled the islet graft survival and functioning for at least 50 days after islet transplantation. The proposed construct can be used to create a reliable pre-vascularized pouch for cell transplantation.

29 October 2015 in Biomacromolecules
Verified
Journal Article
Closed access
TSTomáš Sedlačík
Tomáš Sedlačík
VPVladimír Proks
Vladimír Proks
Miroslav SloufMiroslav Slouf
Miroslav Slouf
MDMiroslava Dušková-Smrčková
Miroslava Dušková-Smrčková
HSHana Studenovska
Hana Studenovska
FRFrantišek Rypáček
František Rypáček

20 March 2011 in Journal of Materials Science: Materials in Medicine
Verified
Journal Article
Closed access
PDF file
TSTomáš Sedlačík
Tomáš Sedlačík
HSHana Studenovska
Hana Studenovska
FRFrantišek Rypáček
František Rypáček

26 July 2024 in Biomacromolecules
Verified
Journal Article
Closed access
PYPeitao Yu
Peitao Yu
TSTomáš Sedlačík
Tomáš Sedlačík
LPLaurens Parmentier
Laurens Parmentier
FJFlorica Adriana Jerca
Florica Adriana Jerca
VJValentin Victor Jerca
Valentin Victor Jerca
Richard HoogenboomRichard Hoogenboom
Richard Hoogenboom